|
Anti-Cancer Effects of Tyrosol on Breast Cancer Cell Line- Exploring the Action Mechanisms
|
Rana Khosravi   , Behdokht Jamali *  , Morvarid Heidari |
|
|
|
Abstract: (629 Views) |
Background: Breast cancer is one of the most common malignancies in women for which no suitable treatment has been found yet. Therefore, the present study studied the cytotoxicity effects of tyrosol (TRY) on the Michigan Cancer Foundation-7 (MCF7) breast cancer cell line and L929 normal cells.
Methods: MCF7 and L929 cells were cultured red in DMEM-F12 culture medium after preparation and then exposed to 0, 100, 200, and 300 μM of TRY for 72 hours. Cell viability was evaluated using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay, and apoptotic and necrotic cell percentages were determined by flow cytometry. After designing specific primers, the expression levels of bax, p53, and bcl-2 genes were evaluated by RT-PCR. GraphPad Prism software was used for analyzing the data.
Results: TRY-treated MCF7 cells showed significantly decreased cell viability in a dose-depended manner. Also, the cell treated with high concentrations of TRY (200 and 300 µM) had a high rate of apoptosis and necrosis (P<0.0001). Reactive oxygen species (ROS) content increased in TRY-treated MCF7 cells. Moreover, the overexpression of bax and p53 and downregulation of bcl-2 was seen in TRY-treated MCF7 cells.
Conclusion: TRY has anticancer effects on breast cancer cells by the induction of oxidative stress and apoptosis, as well as the regulation of genes involved in the process of mitochondrial apoptosis. |
|
|
| Keywords: Breast cancer, Gene, miRNA, Doxorubicin |
|
|
Full-Text [PDF 909 kb]
(123 Downloads)
|
Type of Study: Research |
Subject:
Human Genetics
Received: 2023/06/3 | Accepted: 2023/06/25 | Published: 2023/06/27
|
|
|
|
|
|
|
| References |
1. Sancho-Garnier H, Colonna M. [Breast cancer epidemiology]. Presse Med. 2019;48(10):1076-84. [ DOI:10.1016/j.lpm.2019.09.022] [ PMID] 2. Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. The Lancet Global Health. 2020;8(8):e1027-e37. [ DOI:10.1016/S2214-109X(20)30215-1] [ PMID] 3. Waks AG, Winer EP. Breast cancer treatment: a review. Jama. 2019;321(3):288-300. [ DOI:10.1001/jama.2018.19323] [ PMID] 4. Tang Y, Wang Y, Kiani MF, Wang B. Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer. Clinical Breast Cancer. 2016;16(5):335-43. [ DOI:10.1016/j.clbc.2016.05.012] [ PMID] 5. Luo F, Gu J, Chen L, Xu X. Systems pharmacology strategies for anticancer drug discovery based on natural products. Molecular biosystems. 2014;10(7):1912-7. [ DOI:10.1039/c4mb00105b] [ PMID] 6. Khan MI, Bouyahya A, Hachlafi NEL, Menyiy NE, Akram M, Sultana S, et al. Anticancer properties of medicinal plants and their bioactive compounds against breast cancer: a review on recent investigations. Environmental Science and Pollution Research. 2022;29(17):24411-44. [ DOI:10.1007/s11356-021-17795-7] [ PMID] 7. Aissa I, Abdelkafi-Koubaa Z, Chouaïb K, Jalouli M, Assel A, Romdhane A, et al. Glioblastoma-specific anticancer activity of newly synthetized 3,5-disubstituted isoxazole and 1,4-disubstituted triazole-linked tyrosol conjugates. Bioorganic Chemistry. 2021;114:105071. [ DOI:10.1016/j.bioorg.2021.105071] [ PMID] 8. Karković Marković A, Torić J, Barbarić M, Jakobušić Brala C. Hydroxytyrosol, Tyrosol and Derivatives and Their Potential Effects on Human Health. Molecules [Internet]. 2019; 24(10). [ DOI:10.3390/molecules24102001] [ PMID] [ ] 9. Bahrani HMH, Ghobeh M, Homayouni Tabrizi M. The anticancer, anti-oxidant, and antibacterial activities of chitosan-lecithin-coated parthenolide/tyrosol hybrid nanoparticles. Journal of Biomaterials Science, Polymer Edition. 2023:1-15. [ DOI:10.1080/09205063.2023.2177473] [ PMID] 10. Terzuoli E, Giachetti A, Ziche M, Donnini S. Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation. Molecular nutrition & food research. 2016;60(3):519-29. [ DOI:10.1002/mnfr.201500498] [ PMID] 11. Zhao B, Ma Y, Xu Z, Wang J, Wang F, Wang D, et al. Hydroxytyrosol, a natural molecule from olive oil, suppresses the growth of human hepatocellular carcinoma cells via inactivating AKT and nuclear factor-kappa B pathways. Cancer Lett. 2014;347(1):79-87. [ DOI:10.1016/j.canlet.2014.01.028] [ PMID] 12. Calderón-Montaño JM, Madrona A, Burgos-Morón E, Orta ML, Mateos S, Espartero JL, et al. Selective cytotoxic activity of new lipophilic hydroxytyrosol alkyl ether derivatives. J Agric Food Chem. 2013;61(21):5046-53. [ DOI:10.1021/jf400796p] [ PMID] 13. Owen RW, Giacosa A, Hull WE, Haubner R, Spiegelhalder B, Bartsch H. The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. European Journal of Cancer. 2000;36(10):1235-47. [ DOI:10.1016/S0959-8049(00)00103-9] [ PMID] 14. Li Y, Huang W, Huang S, Du J, Huang C. Screening of anti-cancer agent using zebrafish: comparison with the MTT assay. Biochemical and biophysical research communications. 2012;422(1):85-90.
https://doi.org/10.1016/j.bbrc.2019.01.051 [ DOI:10.1016/j.bbrc.2012.04.110] 15. Loetchutinat C, Kothan S, Dechsupa S, Meesungnoen J, Jay-Gerin J-P, Mankhetkorn S. Spectrofluorometric determination of intracellular levels of reactive oxygen species in drug-sensitive and drug-resistant cancer cells using the 2′, 7′-dichlorofluorescein diacetate assay. Radiation Physics and Chemistry. 2005;72(2-3):323-31. [ DOI:10.1016/j.radphyschem.2004.06.011] 16. Floor SL, Dumont JE, Maenhaut C, Raspe E. Hallmarks of cancer: of all cancer cells, all the time? Trends in Molecular Medicine. 2012;18(9):509-15. [ DOI:10.1016/j.molmed.2012.06.005] [ PMID] 17. Pérez-Tomás R, Montaner B, Llagostera E, Soto-Cerrato V. The prodigiosins, proapoptotic drugs with anticancer properties. Biochemical Pharmacology. 2003;66(8):1447-52. [ DOI:10.1016/S0006-2952(03)00496-9] [ PMID] 18. Tavsan Z, Kayali HA. Flavonoids showed anticancer effects on the ovarian cancer cells: Involvement of reactive oxygen species, apoptosis, cell cycle and invasion. Biomedicine & Pharmacotherapy. 2019;116:109004. [ DOI:10.1016/j.biopha.2019.109004] [ PMID] 19. Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. Journal of the American College of Surgeons. 2004;198(1):83-90. [ DOI:10.1016/j.jamcollsurg.2003.08.008] [ PMID] 20. Changizi Z, Moslehi A, Rohani AH, Eidi A. Chlorogenic acid induces 4T1 breast cancer tumor's apoptosis via p53, Bax, Bcl‐2, and caspase‐3 signaling pathways in BALB/c mice. Journal of Biochemical and Molecular Toxicology. 2021;35(2):e22642. [ DOI:10.1002/jbt.22642] [ PMID] 21. Ramadan MA, Shawkey AE, Rabeh MA, Abdellatif AO. Expression of P53, BAX, and BCL-2 in human malignant melanoma and squamous cell carcinoma cells after tea tree oil treatment in vitro. Cytotechnology. 2019;71(1):461-73. [ DOI:10.1007/s10616-018-0287-4] [ PMID] [ ] 22. Kaloni D, Diepstraten ST, Strasser A, Kelly GL. BCL-2 protein family: Attractive targets for cancer therapy. Apoptosis. 2023;28(1-2):20-38. [ DOI:10.1007/s10495-022-01780-7] [ PMID] [ ] |
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
|
